- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02309931
ISOperistaltic Versus ANTIperistaltic Anastomosis After Laparoscopic Right Colectomy for Cancer (ISOVANTI)
March 6, 2023 updated by: Jesus Abrisqueta Carrion, Hospital Universitario Virgen de la Arrixaca
Randomized Clinical Trial Comparing Isoperistaltic Versus Antiperistaltic Side to Side Anastomosis After Right Laparoscopic Hemicolectomy for Cancer.
The study will provide a precise control compared to the two interventions (iso vs antiperistaltic anastomoses) with thorough measurements of the postoperative variables and complications to improve the evaluation of the surgical technique.
It will also enable an evaluation of the quality of life after the procedures.
Study Overview
Status
Completed
Study Type
Interventional
Enrollment (Actual)
108
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Murcia, Spain, 30120
- Hospital Universitario Virgen de la Arrixaca
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- The patient has given informed consent to participate
- No surgery contraindications
- Elective surgery
- No pregnancy or nursery during the study
- Older than 18 years
- Complete preoperative cancer staging
Tumour characteristics:
- Cecum, ascending, hepatic angle or transverse colon tumour confirmed by endoscopic biopsy
- Radiologically resectable tumours
- Absence of vascular, nervous or bone infiltration
- T4 stages with near organ infiltration
- Absence of peritoneal carcinomatosis
- Absence of respiratory pathology that prevents for doing hydrogen breath test
Exclusion Criteria:
- Pregnancy
- Intestinal bowel disease like Crohn's disease or ulcerative colitis.
- Metastatic bone illness
- Previous abdominal surgery with bowel resection
- Malabsorption syndromes
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Isoperistaltic anastomosis
Patients with right colon cancer who undergo a right laparoscopic hemicolectomy and a isoperistaltic side-to-side ileocecal anastomosis
|
Right laparoscopic hemicolectomy+isoperistaltic side-to-side ileocecal anastomosis
|
Active Comparator: Antiperistaltic anastomosis
Patients with right colon cancer who undergo a right laparoscopic hemicolectomy and a antiperistaltic side-to-side ileocecal anastomosis
|
Right laparoscopic hemicolectomy + antiperistaltic side-to-side ileocecal anastomosis
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
postoperative complications
Time Frame: within the first 30 days up to one year after surgery
|
Number of patients with postoperative complications and grade of Clavien-Dindo
|
within the first 30 days up to one year after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Operating time
Time Frame: During surgery
|
During surgery
|
|
Anastomosis time
Time Frame: From the enteromy to its closure.
|
From the enteromy to its closure.
|
|
Hospital length of say
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 4 days
|
participants will be followed for the duration of hospital stay, an expected average of 4 days
|
|
first tolerance day
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 4 days
|
First day taking liquids without vomits or abdominal distension
|
participants will be followed for the duration of hospital stay, an expected average of 4 days
|
first flatus day
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 4 days
|
participants will be followed for the duration of hospital stay, an expected average of 4 days
|
|
first faeces day
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 4 days
|
participants will be followed for the duration of hospital stay, an expected average of 4 days
|
|
Orocecal transit
Time Frame: up to one year
|
Using hydrogen breath test curves.
preoperative, at day 2 postoperative, 1 month, 6 months and 1 year.
|
up to one year
|
Gastrointestinal life quality
Time Frame: up to one year
|
Using gastrointestinal quality life index questionnaire.
preoperative, 1 month, 6 months and 1 year.
|
up to one year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Juan Lujan, Ph D, Hospital Universitario Virgen de la Arrixaca
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Ibanez N, Abrisqueta J, Lujan J, Hernandez Q, Rufete MD, Parrilla P. Isoperistaltic versus antiperistaltic ileocolic anastomosis. Does it really matter? Results from a randomised clinical trial (ISOVANTI). Surg Endosc. 2019 Sep;33(9):2850-2857. doi: 10.1007/s00464-018-6580-7. Epub 2018 Nov 13.
- Ibanez N, Abrisqueta J, Lujan J, Hernandez Q, Parrilla P. Isoperistaltic versus antiperistaltic side-to-side anastomosis after right laparoscopic hemicolectomy for cancer (ISOVANTI) trial: study protocol for a randomised clinical trial. Int J Colorectal Dis. 2017 Sep;32(9):1349-1356. doi: 10.1007/s00384-017-2840-6. Epub 2017 Jun 21.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2014
Primary Completion (Actual)
November 1, 2016
Study Completion (Actual)
November 1, 2017
Study Registration Dates
First Submitted
November 28, 2014
First Submitted That Met QC Criteria
December 3, 2014
First Posted (Estimate)
December 5, 2014
Study Record Updates
Last Update Posted (Estimate)
March 7, 2023
Last Update Submitted That Met QC Criteria
March 6, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CCR-HCUVA-2014-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Primary Malignant Neoplasm of Ascending Colon
-
Shoichi Fujii, MD, PhDUnknownMalignant Neoplasm of Transverse Colon | Malignant Neoplasm of Descending ColonJapan
-
Fundació Institut de Recerca de l'Hospital de la...RecruitingColon Cancer | Malignant Neoplasm | Colon Neoplasm, Malignant | Colon Neoplasm | Colon NeoplasiaSpain
-
Barbara Ann Karmanos Cancer InstituteCompletedColorectal Cancer | Pancreatic Cancer | Colon Carcinoma | Cancer of Pancreas | Pancreatic Neoplasm | Malignant Neoplasm of Large Intestine | Cancer of Colon | Malignant Tumor of ColonUnited States
-
Dartmouth-Hitchcock Medical CenterCompletedPrimary Malignant Neoplasm of Lung | Primary Malignant Neoplasm of Gastrointestinal TractUnited States
-
Mirati Therapeutics Inc.Boehringer IngelheimCompletedMetastatic Cancer | Advanced Cancer | Malignant Neoplasm of Colon | Malignant Neoplasm of Lung | Malignant Neoplastic DiseaseUnited States
-
Sahlgrenska University Hospital, SwedenThe Swedish Research Council; Sjöbergstiftelsen; VGregionRecruitingGynecologic Cancer | Malignant Neoplasm | Malignant Neoplasm of Large Intestine | Malignant Neoplasm of Colon | Malignant Neoplasm of Prostate | Malignant Neoplasm of Rectum | Malignant Neoplasm of Anus | Malignant Neoplasm of Urinary Bladder | Malignant Neoplasm of Cervix | Malignant Neoplasm of OvarySweden
-
The Cleveland ClinicCompletedBenign Neoplasm of Intestinal Tract | Primary Malignant Neoplasm of Intestinal Tract | Secondary Malignant Neoplasm of Intestinal TractUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAdvanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Metastatic Malignant Neoplasm in the Liver | Metastatic Malignant Neoplasm in the LungUnited States
-
Methodist Health SystemRecruitingPancreatic Malignant Neoplasm PrimaryUnited States
-
Tata Medical CenterCompletedMalignant Neoplasm of Oropharynx Stage III | Malignant Neoplasm of Larynx Stage III | Malignant Neoplasm of Hypopharynx Stage III | Malignant Neoplasm of Oropharynx Stage IVa | Malignant Neoplasm of Oropharynx Stage IVb | Malignant Neoplasm of Larynx Stage IV | Malignant Neoplasm of Hypopharynx... and other conditionsIndia
Clinical Trials on isoperistaltic side-to-side ileocecal anastomosis
-
Tianjin Medical University Cancer Institute and...RecruitingEpiphora Due to Insufficient Drainage, Left Side | Epiphora Due to Insufficient Drainage, Right SideChina
-
Federico II UniversityUnknown
-
Sawai Mansingh Medical CollegeCompletedIleus | Bowel Obstruction | Stoma Ileostomy | Anastomosis | Stoma Colostomy | Leak, AnastomoticIndia
-
Tianjin Medical University Cancer Institute and...Unknown
-
Weill Medical College of Cornell UniversityCrohn's and Colitis FoundationRecruitingCrohn's DiseaseUnited States, Germany, Italy, Belgium, Finland, Spain
-
Academisch Medisch Centrum - Universiteit van Amsterdam...ZonMw: The Netherlands Organisation for Health Research and DevelopmentRecruiting
-
Weill Medical College of Cornell UniversityCrohn's & Colitis Foundation of America, Inc.Enrolling by invitation
-
Peking University Third HospitalBeihang UniversityCompletedKnee Ligament; LaxityChina
-
GT Metabolic Solutions, Inc.Active, not recruitingObesityBelgium, Canada, Georgia, Spain
-
Ludwig-Maximilians - University of MunichUnknownRectal Cancer | Rectal Neoplasms | Fecal Incontinence | Rectal TumorsGermany